spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

PCI Appoints Two New additions to its Commercial Packaging Sales Team

PCI Pharma Services

Philadelphia, USA – July 31, 2017

Leading outsourcing provider PCI Pharma Services has announced the appointment of Nigel Hindes and Laurent Rozier as Business Development Managers. They both join PCI to support the development of the company’s commercial packaging business across Europe.

Both Hindes and Rozier will support a number of key accounts and help drive the continued growth of PCI’s business in Europe. Their main focus will be the growth of PCI’s commercial packaging business, primarily from the Hay-on-Wye facility in the UK. With significant investment in Serialization capabilities, their appointments have come at a critical time as PCI furthers its work with clients on strategies to address the European Falsified Medicines Directive (EU FMD).

Hindes will have responsibility for the UK and Ireland, and has previously worked with other leading contract manufacturing organizations (CMO) providing pharmaceutical manufacturing and packaging services. He also has extensive sales experience within the fast-moving consumer goods industry (FMCG) in Europe and brings substantial knowledge and expertise to PCI’s commercial packaging services. This includes primary and secondary packaging, analytical laboratory services, and QP services, as well as working with clients to prepare them for the implementation of Serialization.
 
Rozier, who will be based in France, will be responsible for supporting the growth of PCI’s business in Southern Europe. He brings more than ten years’ experience of working within the pharmaceutical packaging industry, providing companies with innovative solutions designed to enhance product shelf-life and quality. He has worked with many of the industry’s major pharmaceutical companies, and his insights and expertise will continue to enable PCI to provide packaging solutions and technologies that truly differentiate products.

Commenting on both appointments, Robbie Stewart, Business Development Director at PCI, stated: “We are delighted to welcome Nigel and Laurent to the commercial packaging team. They both bring a great deal of experience and a proven track record in business development across the pharma sector.

“The commercial packaging business in Europe has seen robust growth in the last few years as we continue to deliver outstanding service to our clients. I am sure that both will be successful in their roles and their knowledge will be invaluable in supporting customers as they look for innovative thinking in bringing new medicines products to market.”

Hindes stated: “I am very excited to join PCI at a time when we are seeing such interest in our commercial packaging business, from Serialization services to the growth of biological medicines that we support from our Hay-on-Wye site. I look forward to leveraging my experience and the considerable expertise at PCI to deliver clients the industry’s leading experience.”

Rozier added: “I am thrilled to be joining PCI Pharma Services at such an exciting time as the business continues to expand, and I’m particularly excited to be working with companies across Europe to help drive further commercial growth for PCI.”

To find out more about PCI, please visit www.pciservices.com.

About PCI


The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over four decades in the healthcare business. Leading technology and continued investment enables us to address global development needs throughout the product life cycle — from Phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives. For more information, please visit
www.pciservices.com  or follow us on Twitter at @PCI_Social.

Contact

Chantel Richman / Fotini Efstathiou at Remarkable Content
chantel.richman@remarkablegroup.co.uk / Fotini@remarkablegroup.co.uk

 T: 0117 247 0158 / 01962 853 929
phone +44 (0)1495 713 633
email sales@pciservices.com
web www.pciservices.com
email Wye Valley Business Park, Hay-on-Wye, HR3 5PG
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Kloeckner Pentaplast Announces Plans for New Lamination Facility


More info >>


White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

Industry Events

Global Bioproduction Summit, 5th-6th February 2018

5-6 February 2018, Hilton San Diego Resort & Spa, CA

After 15 years in Europe, the Global Bioproduction Summit moved to its new home of San Diego in 2016. The Bioproduction Summit delves deep into the world of biological production.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement